Abstract
Background
Cervical cancer is one of the most common and fatal malignancies among females, and biomarkers are essential for assisting in its management. Kinesin family member 2A (KIF2A) has been exhibited to be a potential maker in various cancers; however, its role in cervical cancer has yet to be reported. Therefore, we aimed to assess the expression of KIF2A and its correlation with clinicopathological characteristics as well as survival profile in cervical cancer patients.
Methods
A hundred and thirty-five cervical cancer patients who underwent simple trachelectomy or radical hysterectomy were retrospectively analyzed. Tumor tissues and paired adjacent tissues were acquired, in which KIF2A mRNA and protein expressions were determined by reverse transcription quantitative polymerase chain reaction and immunohistochemistry assay, respectively. Disease-free survival (DFS) and overall survival (OS) were documented with a median follow-up duration of 28.0 months.
Results
KIF2A protein (P < 0.001) and mRNA (P < 0.001) expressions were both upregulated in tumor tissues compared to paired adjacent tissues in cervical cancer patients. In addition, tumor tissue KIF2A protein and mRNA expressions were positively associated with lymph node metastasis (P = 0.025 and P = 0.010, respectively) and FIGO stage (P = 0.022 and P = 0.015, respectively) in cervical cancer patients. Moreover, patients with tumor tissue KIF2A high expression (mRNA and protein) displayed worse DFS (P = 0.010 and P = 0.046, respectively) and OS (P = 0.042 and P = 0.030, respectively) compared to patients with tumor tissue KIF2A low expression (mRNA and protein).
Conclusion
Tumor tissue KIF2A expression could serve as a biomarker enhancing the disease surveillance and prognostication in cervical cancer management.
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7–30. https://doi.org/10.3322/caac.21442
Minion LE, Tewari KS (2018) Cervical cancer - state of the science: from angiogenesis blockade to checkpoint inhibition. Gynecol Oncol 148(3):609–621. https://doi.org/10.1016/j.ygyno.2018.01.009
Li H, Wu X, Cheng X (2016) Advances in diagnosis and treatment of metastatic cervical cancer. J Gynecol Oncol 27(4):e43. https://doi.org/10.3802/jgo.2016.27.e43
Noda Y, Niwa S, Homma N et al (2012) Phosphatidylinositol 4-phosphate 5-kinase alpha (PIPKalpha) regulates neuronal microtubule depolymerase kinesin, KIF2A and suppresses elongation of axon branches. Proc Natl Acad Sci U S A 109(5):1725–1730. https://doi.org/10.1073/pnas.1107808109
Parrini E, Conti V, Dobyns WB, Guerrini R (2016) Genetic basis of brain malformations. Mol Syndromol 7(4):220–233. https://doi.org/10.1159/000448639
Xie T, Li X, Ye F et al (2018) High KIF2A expression promotes proliferation, migration and predicts poor prognosis in lung adenocarcinoma. Biochem Biophys Res Commun 497(1):65–72. https://doi.org/10.1016/j.bbrc.2018.02.020
Sheng N, Xu YZ, Xi QH et al (2018) Overexpression of KIF2A is suppressed by miR-206 and associated with poor prognosis in ovarian cancer. Cell Physiol Biochem 50(3):810–822. https://doi.org/10.1159/000494467
Zhang Y, You X, Liu H et al (2017) High KIF2A expression predicts unfavorable prognosis in diffuse large B cell lymphoma. Ann Hematol 96(9):1485–1491. https://doi.org/10.1007/s00277-017-3047-1
Colombo N, Carinelli S, Colombo A et al (2012) Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii27–vii32. https://doi.org/10.1093/annonc/mds268
Hu Z, Gu X, Zhong R et al (2018) Tumor-infiltrating CD45RO(+) memory cells correlate with favorable prognosis in patients with lung adenocarcinoma. J Thorac Dis 10(4):2089–2099. https://doi.org/10.21037/jtd.2018.03.148
Tian Y, Zhao K, Yuan L et al (2018) EIF3B correlates with advanced disease stages and poor prognosis, and it promotes proliferation and inhibits apoptosis in non-small cell lung cancer. Cancer Biomark 23(2):291–300. https://doi.org/10.3233/CBM-181628
Wang D, Zhu H, Ye Q et al (2016) Prognostic value of KIF2A and HER2-Neu overexpression in patients with epithelial ovarian cancer. Medicine (Baltimore) 95(8):e2803. https://doi.org/10.1097/MD.0000000000002803
Zhao P, Lan F, Zhang H et al (2018) Down-regulation of KIF2A inhibits gastric cancer cell invasion via suppressing MT1-MMP. Clin Exp Pharmacol Physiol 45(10):1010–1018. https://doi.org/10.1111/1440-1681.12974
Zhang Q, Lu D, Liu W et al (2019) Effects of KIF2A on the prognosis of nasopharyngeal carcinoma and nasopharyngeal carcinoma cells. Oncol Lett 18(3):2718–2723. https://doi.org/10.3892/ol.2019.10597
Zhang S, Huang F, Wang Y et al (2016) KIF2A overexpression and its association with clinicopathologic characteristics and poor prognoses in patients with gastric cancer. Dis Markers 2016:7484516–7484519. https://doi.org/10.1155/2016/7484516
Wang ZX, Ren SC, Chang ZS, Ren J (2020) Identification of kinesin family member 2A (KIF2A) as a promising therapeutic target for osteosarcoma. Biomed Res Int 2020:7102757–7102759. https://doi.org/10.1155/2020/7102757
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The current study was approved by the Institutional Review Board. Patients or their guardians provided the written informed consents.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lei, G., Xin, X. & Hu, X. Clinical significance of kinesin family member 2A as a facilitating biomarker of disease surveillance and prognostication in cervical cancer patients. Ir J Med Sci 191, 665–670 (2022). https://doi.org/10.1007/s11845-021-02510-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-021-02510-9